Improve MEK/ERK targeting in mutant KRAS lung cancer

被引：0
|
作者：
Chen, Zhao [1 ]
Weisberg, Ellen [1 ]
Cheng, Katherine [1 ]
Kung, Andrew L. [2 ]
Bradner, James [1 ]
Griffin, James [1 ]
Wong, Kwok-Kin [1 ]
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Columbia Univ, New York, NY USA
来源：
MOLECULAR CANCER RESEARCH | 2014年 / 12卷
关键词：
D O I：
10.1158/1557-3125.RASONC14-B01
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B01
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Targeting MEK in KRAS mutant lung cancer
    Jaenne, Pasi A.
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [2] Dual Targeting of Autophagy and MEK in KRAS Mutant Cancer
    Zhao, Hongyun
    Zheng, Bin
    TRENDS IN CANCER, 2019, 5 (06): : 327 - 329
  • [3] Back to the Bench? MEK and ERK Inhibitors for the Treatment of KRAS Mutant Lung Adenocarcinoma
    Kohler, Jens
    Catalano, Marco
    Ambrogio, Chiara
    CURRENT MEDICINAL CHEMISTRY, 2018, 25 (05) : 558 - 574
  • [4] Targeting metabolic vulnerability in mitochondria conquers MEK inhibitor resistance in KRAS-mutant lung cancer
    Juanjuan Feng
    Zhengke Lian
    Xinting Xia
    Yue Lu
    Kewen Hu
    Yunpeng Zhang
    Yanan Liu
    Longmiao Hu
    Kun Yuan
    Zhenliang Sun
    Xiufeng Pang
    Acta Pharmaceutica Sinica B, 2023, (03) : 1145 - 1163
  • [5] Targeting metabolic vulnerability in mitochondria conquers MEK inhibitor resistance in KRAS-mutant lung cancer
    Feng, Juanjuan
    Lian, Zhengke
    Xia, Xinting
    Lu, Yue
    Hu, Kewen
    Zhang, Yunpeng
    Liu, Yanan
    Hu, Longmiao
    Yuan, Kun
    Sun, Zhenliang
    Pang, Xiufeng
    ACTA PHARMACEUTICA SINICA B, 2023, 13 (03) : 1145 - 1163
  • [6] Targeting immunosuppressive mechanisms in KRAS mutant lung cancer
    Havel, Lauren Smith
    Gao, Dingcheng
    Daniel, Jennifer S.
    Altorki, Nasser K.
    Mittal, Vivek
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (02) : S23 - S24
  • [7] Targeting KRAS mutant lung cancer: light at the end of the tunnel
    Drosten, Matthias
    Barbacid, Mariano
    MOLECULAR ONCOLOGY, 2022, 16 (05) : 1057 - 1071
  • [8] A combination therapy for KRAS-mutant lung cancer by targeting synthetic lethal partners of mutant KRAS
    Xiufeng Pang
    Mingyao Liu
    Chinese Journal of Cancer, 2016, 35 (11) : 571 - 573
  • [9] A combination therapy for KRAS-mutant lung cancer by targeting synthetic lethal partners of mutant KRAS
    Pang, Xiufeng
    Liu, Mingyao
    CHINESE JOURNAL OF CANCER, 2016, 35 : 92
  • [10] Targeting KRAS-mutant pancreatic cancer through simultaneous inhibition of KRAS, MEK, and JAK2
    Miyazaki, Satoru
    Kitazawa, Masato
    Nakamura, Satoshi
    Koyama, Makoto
    Yamamoto, Yuta
    Hondo, Nao
    Kataoka, Masahiro
    Tanaka, Hirokazu
    Takeoka, Michiko
    Komatsu, Daisuke
    Soejima, Yuji
    MOLECULAR ONCOLOGY, 2025, 19 (02) : 377 - 390
12345